Publications by authors named "Lisa Macpherson"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

213

Total Likes

630

Extended Reach

3,392,537

Social Features

201
O
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment.
Sean Wharton, Louis J Aronne, Adam Stefanski, Nasreen F Alfaris, Andreea Ciudin, Koutaro Yokote, Bruno Halpern, Alpana P Shukla, Chunmei Zhou, Lisa Macpherson

N Engl J Med· November 2025

Videos about Article: user user

2 12 50 187 35 43 2 17 15

View All Article and Social Media Activity
E
Evaluating viral load sampling schemes and swabbing methods for optimal surrogacy.
Allyson Mateja, Eric Chu, Thomas A Murray, Carolyn T Bramante, Carlee Moser, Lisa Farmer Macpherson

J Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death.
Allyson Mateja, Eric Chu, Thomas A Murray, Carolyn T Bramante, Carlee Moser, Lisa Farmer Macpherson

J Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19.
Dipak R Patel, Lisa Macpherson, Martin Bohm, Himanshu Upadhyaya, Carmen Deveau

Infect Dis Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial.
Russell M Nichols, Lisa Macpherson, Dipak R Patel, Wendy W Yeh, Amanda Peppercorn

Infect Dis Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial.
Himanshu P Upadhyaya, Jenny Y Chien, Amanda J Long, Martin S Bohm, Nicole L Kallewaard, Lisa F Macpherson

Infect Dis Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative performance of composite measures from two phase III clinical trials of ixekizumab in psoriatic arthritis.
Laura C Coates, Josef S Smolen, Philip J Mease, M Elaine Husni, Joseph F Merola, Lisa Macpherson

RMD Open· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2).
Ana-Maria Orbai, Jordi Gratacós, Anthony Turkiewicz, Stephen Hall, Eva Dokoupilova, Lisa Macpherson

Rheumatol Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein trafficking in the mitochondrial intermembrane space: mechanisms and links to human disease.
Lisa MacPherson, Kostas Tokatlidis

Biochem J· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxidative protein biogenesis and redox regulation in the mitochondrial intermembrane space.
Phanee Manganas, Lisa MacPherson, Kostas Tokatlidis

Cell Tissue Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis